Tae Heung Kang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Cancer immunology, immunotherapy : CII

Journal for immunotherapy of cancer

Oncoimmunology

Drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Eun Won, Youngseon Byeon, Tae In Wi, Chan Mi Lee, Ju Hyeong Lee, Tae Heung Kang, Jeong-Won Lee, YoungJoo Lee, Yeong-Min Park, Hee Dong Han
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches. Journal for immunotherapy of cancer 10 (2) (2022)
Sung Eun Lee, Gun-Young Jang, Ji Won Lee, Sang Hyeon Park, Hee Dong Han, Yeong-Min Park, Tae Heung Kang
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer. Cancer immunology, immunotherapy : CII 71 (12) (2022)
Gun-Young Jang, Young Seob Kim, Sung Eun Lee, Ji Won Lee, Hee Dong Han, Tae Heung Kang, Yeong-Min Park
Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors. Cancer immunology, immunotherapy : CII 70 (4) (2020)
Hyun Jin Park, Gun-Young Jang, Young Seob Kim, Jung Hwa Park, Sung Eun Lee, Manh-Cuong Vo, Je-Jung Lee, Hee Dong Han, In Duk Jung, Tae Heung Kang, Yeong-Min Park
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine. Journal for immunotherapy of cancer 7 (1) (2019)
Young Seob Kim, Hyun Jin Park, Jung Hwa Park, Eun Ji Hong, Gun-Young Jang, In Duk Jung, Hee Dong Han, Seung-Hyun Lee, Manh-Cuong Vo, Je-Jung Lee, Andrew Yang, Emily Farmer, T-C Wu, Tae Heung Kang, Yeong-Min Park
A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells. Oncoimmunology 7 (10) (2018)
Ga Hee Kim, Ji Eun Won, Yeongseon Byeon, Min Gi Kim, Tae In Wi, Jae Myeong Lee, Yun-Yong Park, Jeong-Won Lee, Tae Heung Kang, In Duk Jung, Byung Cheol Shin, Hyung Jun Ahn, Young Joo Lee, Anil K Sood, Hee Dong Han, Yeong-Min Park
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer. Drug delivery 25 (1) (2018)

Tae Heung Kang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tae Heung Kang